Monday, January 31, 2000
While some Swedish biotech companies are worried that the exit
of Pharmacia and Astra could limit their local opportunities, Active Biotech AB is betting that refocusing its efforts in the growing biotech center in the
Medicon Valley region of Southern Sweden and Northern Denmark will pay off.
The company is leaving its offices in Cambridge, U.K., Europe's hottest biotech
cluster, to fulfill a promise made to shareholders to save money.
Active (SSE:ACTI, Lund, Sweden) is shifting all the preclinical
research now based at Actinova Ltd. (Cambridge) to Lund and has sold its SBL
Vaccins premises in